The Sentinel System is an increasingly vital tool in FDA's post-marketing safety surveillance system for medical products, e.g., drugs, vaccines, and medical devices. This webinar provided an overview of Sentinel's story, successes, and ongoing value. The webinar also described the efforts and impact of a multi-stakeholder engagement work group in developing tailored messages about Sentinel and identifying dissemination channels to reach a diverse audience. This webinar was open to the public.
Tyler D. Coyle MD, MS, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Stephen J. Mikita JD, Sentinel Planning Board Member, Patient Advocate, FDA Patient Representative